Vancouver, BC, March 9, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its wholly-owned subsidiary, Edison Vape Co. Ltd. (“Edison”) has received pre-production samples of the Edison device and functional testing has been started. Preliminary testing has indicated extremely positive results and has confirmed the effectiveness of the Edison POD system.
In order to bring the best device possible to market, several design and functionality enhancements have been identified and Edison is currently improving some of the molds and tooling. This fine-tuning will delay the expected launch date to the Company’s second quarter, resulting in a substantially better product for consumers. Further details regarding the launch timing will be provided in the coming weeks once the design enhancements have been completed.
Ryan Selby, CEO of Edison, commented, “The initial working prototype has exceeded our expectations in terms of performance and versatility, and in order to provide the best possible device to consumers, we have identified a number of practical improvements which are being implemented now. We are currently in the process of updating the required molds and tooling, and we look forward to receiving the next round of pre-production samples within the next 45-60 days.”
Edison has also filed for US trademark protection for the Edison brand, and is now in the process of completing the Patent Cooperation Treaty (“PCT”) International Patent application based on the priority filing date of April 29th, 2015. The Edison POD system includes a host of innovative and novel features which will provide Edison with a significant competitive advantage over existing vaporization devices, and filing for the PCT Patent will provide many advantages for Edison. The PCT Patent application will extend the deadline to apply for national Patent protection in most foreign countries until October 29th, 2017, preserving our ability to protect the valuable intellectual property on a global scale.
About Edison Vape Co. Ltd.
Edison Vape Co. is engaged in the design, development, patenting, manufacture, and distribution of a new and improved system for vaporization using low cost single-use PODs. The founders of Edison Vape Co. have a combined 13 years of experience designing, developing, patenting, manufacturing, and distributing innovative products and accessories.
About Invictus MD Strategies Corp.
Invictus MD targets companies with proven brands, strong customer focus, and significant growth potential. We not only provide capital to meet these objectives but also years of management experience from a team that has been successful in all facets of business from start-ups to running large international organizations. The fundamental core of our operations is centered on the vast opportunities within fragmented industries.
Invictus MD works in partnership with management teams to increase shareholder value through business planning and process integration, developing and executing growth strategies, leveraging our experience and relationships, and structuring and deploying the proper capital to support long-term growth. Our prudent approach to both investing in and developing successful companies ensures successful execution of the business plan in both times of economic expansion and contraction.
For more information please visit www.invictus-md.com.
On Behalf of the Board,
Chairman & CEO
Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may contain forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing of Edison Vape Co.’s initial launch of its vaporizer products, are forward-looking statements and contain forward-looking information. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, including that Edison Vape Co.’s vaporizer products will be launched as intended and planned, and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information, including the risks that Edison Vape Co. may not launch its vaporizer products by the second quarter of 2016. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statements or forward-looking information that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbour.